My PCR
Create Account
Logo PCR

17 Nov 2025

TAVI

Meet with Myval THV series with real-world case-based learning

Sponsored by Meril Life Sciences

Anchorperson: F. Maisano
Spokesperson: T. Cuisset
SHOW MORE

Summary

Discover the latest insights from the Myval THV series in this session from PCR London Valves 2025. Through real-world, case-based learning, the session explores lifetime management strategies for TAVI patients, the clinical relevance of intermediate and extra-large valve sizing, and the impact of foreshortening on accurate valve deployment.

Key presentations cover matching prostheses to patient anatomy, the importance of predictable valve performance in challenging situations, and pivotal trial data supporting Myval THV outcomes. Highlights include the OCTAPRO+ THV’s progressive design enabling precise deployment, the OctaAlign technique for commissural alignment, and next-generation strategies to optimize lifetime TAVI management.

Learning Objectives

  • To know about the novel Myval transcatheter heart valve (THV) series and its role in lifetime management of TAVI patients
  • To appreciate the utility of intermediate and extra-large device sizing and the relationship between foreshortening and accurate deployment of THV
  • To hear about pivotal trials of Myval THV series and their relevance in clinical practice
Related Content
PCR London Valves 2025: Best of Social Media Coverage TAVI valve-in-valve - Part 6 Paravalvular leak closure - Part 4
Recommended for you
What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025 ESC Congress 2025: The DOUBLE-CHOICE trial PCR Tokyo Valves 2026: What's on the Programme?